Randomized trial of ceftazidime versus placebo in the management of acute respiratory exacerbations in patients with cystic fibrosis*

https://doi.org/10.1016/S0022-3476(87)80217-2Get rights and content

A randomized trial of ceftazidime versus placebo was conducted in patients with cystic fibrosis hospitalized for acute respiratory exacerbations. Patients 12 years of age or older were included if they had mild to moderately severe illness according to the following criteria: erythrocyte sedimentation rate ≤50 mm/hr and less than three other abnormalities (leukocyte count ≥15,000/μL, pulse≥100 beats/min, respirations ≥30/min, or temperature ≥38.5°C). In all 16 episodes treated with ceftazidime, the patients were rated improved in comparison with 10 of 12 patients treated with placebo. Three placebo-treated patients dropped out of the study within 3 to 5 days because they wanted antibiotic therapy. None of the 15 placebo-treated patients showed clinical deterioration. There were no significant differences in rate of improvement of symptom score, weight gain, or pulmonary function between the two treatment groups. There was no difference in the course during the 6 to 24 months after the study period. Intravenous antibiotics are not essential in the management of all acute respiratory exacerbations of mild to moderate severity in patients with cystic fibrosis.

References (42)

  • BeaudryPH et al.

    Is anti-Pseudomonas therapy warranted in acute respiratory exacerbations in children with cystic fibrosis?

    J Pediatr

    (1980)
  • NelsonJD

    Management of acute pulmonary exacerbations in cystic fibrosis: a critical appraisal

    J Pediatr

    (1985)
  • SmithAL

    Antibiotic therapy in cystic fibrosis: evaluation of clinical trials

    J Pediatr

    (1986)
  • IslesA et al.

    Pseudomonas cepacia infection in cystic fibrosis: an emerging problem

    J Pediatr

    (1984)
  • DesmondKJ et al.

    Immediate and long-term effects of chest physiotherapy in patients with cystic fibrosis

    J Pediatr

    (1983)
  • WoodRE et al.

    Cystic fibrosis

    Am Rev Respir Dis

    (1976)
  • Di Sant'AgnesePA et al.

    Celiac syndrome. IV. Chemotherapy of infections of the respiratory tract associated with cystic fibrosis of the pancreas: observations with penicillin and drugs of the sulfonamide group, with special reference to penicillin acrosol

    Am J Dis Child

    (1946)
  • SchwachmanH et al.

    Aureomycin therapy in the pulmonary involvement of pancreatic fibrosis (mucoviscidosis)

    N Engl J Med

    (1949)
  • LauWK et al.

    Amikacin therapy of exacerbations of Pseudomonas aeruginosa infections in patients with cystic fibrosis

    Pediatrics

    (1977)
  • FriisB

    Chemotherapy of chronic infections with mucoid Pseudomonas aeruginosa in lower airways of patients with cystic fibrosis

    Scand J Infect Dis

    (1979)
  • MøllerNE et al.

    Antibiotic treatment of chronic Pseudomonas aeruginosa infection in cystic fibrosis patients

    Scand J Infect Dis

    (1981)
  • Cited by (0)

    *

    Supported in part by a grant from the Canadian Cystic Fibrosis Foundation.

    View full text